95 related articles for article (PubMed ID: 9022610)
1. Potential enhancement of endometrial receptivity in cycles using controlled ovarian hyperstimulation with antiprogestins: a hypothesis.
Paulson RJ; Sauer MV; Lobo RA
Fertil Steril; 1997 Feb; 67(2):321-5. PubMed ID: 9022610
[TBL] [Abstract][Full Text] [Related]
2. Accelerated endometrial maturation in the luteal phase of cycles utilizing controlled ovarian hyperstimulation: impact of gonadotropin-releasing hormone agonists versus antagonists.
Saadat P; Boostanfar R; Slater CC; Tourgeman DE; Stanczyk FZ; Paulson RJ
Fertil Steril; 2004 Jul; 82(1):167-71. PubMed ID: 15237007
[TBL] [Abstract][Full Text] [Related]
3. The luteal phase of cycles utilizing controlled ovarian hyperstimulation and the possible impact of this hyperstimulation on embryo implantation.
Kolb BA; Paulson RJ
Am J Obstet Gynecol; 1997 Jun; 176(6):1262-7; discussion 1267-9. PubMed ID: 9215183
[TBL] [Abstract][Full Text] [Related]
4. Letrozole administration during the luteal phase after ovarian stimulation impacts corpus luteum function: a randomized, placebo-controlled trial.
Garcia-Velasco JA; Quea G; Piró M; Mayoral M; Ruiz M; Toribio M; Requena A
Fertil Steril; 2009 Jul; 92(1):222-5. PubMed ID: 18710719
[TBL] [Abstract][Full Text] [Related]
5. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients.
Cortínez A; De Carvalho I; Vantman D; Gabler F; Iñiguez G; Vega M
Fertil Steril; 2005 Jan; 83(1):110-5. PubMed ID: 15652895
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes.
Papanikolaou EG; Bourgain C; Kolibianakis E; Tournaye H; Devroey P
Hum Reprod; 2005 Jun; 20(6):1541-7. PubMed ID: 15705618
[TBL] [Abstract][Full Text] [Related]
7. Endometrial estrogen and progesterone receptor and pinopode expression in stimulated cycles of oocyte donors.
Develioglu OH; Hsiu JG; Nikas G; Toner JP; Oehninger S; Jones HW
Fertil Steril; 1999 Jun; 71(6):1040-7. PubMed ID: 10360907
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of endometrial integrins and progesterone receptor during the window of implantation in normo-ovulatory women treated with clomiphene citrate.
Palomino WA; Fuentes A; González RR; Gabler F; Boric MA; Vega M; Devoto L
Fertil Steril; 2005 Mar; 83(3):587-93. PubMed ID: 15749485
[TBL] [Abstract][Full Text] [Related]
9. The incidence of both serious and minor complications in young women undergoing oocyte donation.
Maxwell KN; Cholst IN; Rosenwaks Z
Fertil Steril; 2008 Dec; 90(6):2165-71. PubMed ID: 18249368
[TBL] [Abstract][Full Text] [Related]
10. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
[TBL] [Abstract][Full Text] [Related]
11. Transfer and uterine factors are the major recipient-related determinants of success with donor eggs.
Zenke U; Chetkowski RJ
Fertil Steril; 2004 Oct; 82(4):850-6. PubMed ID: 15482759
[TBL] [Abstract][Full Text] [Related]
12. Controlled ovarian hyperstimulation. Relationship of early serum E2 levels to the ultimate response of oocyte donors.
Kavic S; Cohen MA; Sauer MV; Lindheim SR
J Reprod Med; 2001 Jul; 46(7):637-40. PubMed ID: 11499183
[TBL] [Abstract][Full Text] [Related]
13. Determination of endometrial prolactin in vivo as a marker for endometrial development in spontaneous ovulatory cycles and in vitro fertilization cycles.
Dekker JJ; Martens F; Schoemaker J
Gynecol Endocrinol; 2001 Jun; 15(3):210-8. PubMed ID: 11447733
[TBL] [Abstract][Full Text] [Related]
14. Histochemical localization of endometrial insulin-like growth factor binding protein-1 and -3 during the luteal phase in controlled ovarian hyperstimulation cycles: a controlled study.
Brown SE; Mandelin E; Oehninger S; Toner JP; Seppala M; Jones HW
Fertil Steril; 2000 Aug; 74(2):338-42. PubMed ID: 10927055
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural characteristics of the luteal phase endometrium in patients undergoing controlled ovarian hyperstimulation.
Kolb BA; Najmabadi S; Paulson RJ
Fertil Steril; 1997 Apr; 67(4):625-30. PubMed ID: 9093184
[TBL] [Abstract][Full Text] [Related]
16. Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients.
Stadtmauer L; Harrison DD; Boyd J; Bocca S; Oehninger S
Fertil Steril; 2009 Nov; 92(5):1600-5. PubMed ID: 18990373
[TBL] [Abstract][Full Text] [Related]
17. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial.
Babayof R; Margalioth EJ; Huleihel M; Amash A; Zylber-Haran E; Gal M; Brooks B; Mimoni T; Eldar-Geva T
Hum Reprod; 2006 May; 21(5):1260-5. PubMed ID: 16439507
[TBL] [Abstract][Full Text] [Related]
18. Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles.
Levi AJ; Drews MR; Bergh PA; Miller BT; Scott RT
Fertil Steril; 2001 Oct; 76(4):670-4. PubMed ID: 11591397
[TBL] [Abstract][Full Text] [Related]
19. Effect of levonorgestrel and mifepristone on endometrial receptivity markers in a three-dimensional human endometrial cell culture model.
Meng CX; Andersson KL; Bentin-Ley U; Gemzell-Danielsson K; Lalitkumar PG
Fertil Steril; 2009 Jan; 91(1):256-64. PubMed ID: 18206148
[TBL] [Abstract][Full Text] [Related]
20. Effects of ovarian high response on implantation and pregnancy outcome during controlled ovarian hyperstimulation (with GnRH agonist and rFSH).
Chen QJ; Sun XX; Li L; Gao XH; Wu Y; Gemzell-Danielsson K; Cheng LN
Acta Obstet Gynecol Scand; 2007; 86(7):849-54. PubMed ID: 17611831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
